a2 Milk Eyes China Recovery as $235.8 Million Profit Tests Broader Growth Engines
Updated
Updated · Kalkine Media · Aug 16
a2 Milk Eyes China Recovery as $235.8 Million Profit Tests Broader Growth Engines
2 articles · Updated · Kalkine Media · Aug 16
Summary
China-label infant formula shortages that hit late in the year have largely eased, shifting a2 Milk’s immediate test from fixing supply to winning back users and restoring steadier retail sales.
English-label formula, liquid milk and newer nutrition products are now the main offsets, showing whether growth outside the disrupted China-label channel can keep the group expanding.
Pōkeno’s integration has become central to that effort because tighter manufacturing control should improve product flow and economics, though utilisation, transition timing and working capital remain key execution risks.
Margins and cash conversion will be watched closely at the full-year result after a2 Milk said profitability should land toward the stronger end of guidance; underlying net profit later came in up 7% at $235.8 million.
The broader valuation debate now hinges on whether a2 Milk can pair a durable China-label recovery with disciplined growth across multiple categories rather than simply replacing one engine with another.